Australia's Inventia partners with Merck to develop 3D models for neuro disease drug discovery
Drug Discovery | News | 0 Comment | 17 Feb, 2023
Australia-based startup Inventia Life Science has partnered with American pharmaceutical firm Merck using Inventia'...Read more
Advances in Oncology Drug Development
Drug Discovery | Opinion | By Rachel Webster, Head of Oncology & Biosimilars, Clarivate | 0 Comment | 07 Feb, 2023
Oncology is the growth engine of the pharma industry. The oncology drug market totaled $193 billion in sales in 2021 and...Read more
Drug Discovery | Opinion | By Hithaishi C Bhaskar | 4 Comment | 16 Jan, 2023
Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...Read more
Otsuka and Schrödinger announce single-target, drug discovery partnership in neurology
Drug Discovery | News | 0 Comment | 13 Jan, 2023
Japanese firm Otsuka Pharmaceutical has announced that the company and its UK-based subsidiary Astex Pharmaceuticals are...Read more
BioNTech expands by leveraging AI-powered Drug discovery, design and development
Drug Discovery | News | 0 Comment | 11 Jan, 2023
BioNTech SE and InstaDeep Ltd. have entered partnership under which BioNTech will acquire InstaDeep to build AI-driven d...Read more
Drug Discovery | News | 0 Comment | 30 Dec, 2022
Japan-based startup Veritas In Silico has entered into a joint drug discovery research agreement with RaQualia Pharma to...Read more
China-based startup XtalPi joins hands with Singapore's national platform for cancer drug discovery
Drug Discovery | News | 0 Comment | 21 Dec, 2022
China-based XtalPi, a pioneering pharmaceutical technology startup powered by artificial intelligence (AI) and automatio...Read more
Sosei Heptares & Eli Lilly ink $730 M deal for treatment of diabetes and metabolic diseases
Drug Discovery | News | 0 Comment | 20 Dec, 2022
Japan-based Sosei Group Corporation has entered a drug discovery collaboration with Eli Lilly and Company, to discover, ...Read more
GARDP and Sumitomo Pharma announce partnership in search for new antibiotics
Drug Discovery | News | 0 Comment | 24 Nov, 2022
The Global Antibiotic Research and Development Partnership (GARDP) and Japanese firm Sumitomo Pharma Co. have signed an ...Read more
Chugai extends R&D collaboration in Singapore earmarking S$282M over next 5 years
Drug Discovery | Company results | By Hithaishi C Bhaksar | 8 Comment | 16 Nov, 2022
The Japanese company Chugai Pharmaceutical Co., Ltd., which owns and operates a fully-owned research center "Chugai Phar...Read more
Ono Pharma inks neuro drug discovery collaboration with Captor Therapeutics
Drug Discovery | News | 0 Comment | 15 Nov, 2022
Japan-based Ono Pharmaceutical has entered a worldwide drug discovery collaboration agreement with Poland's Captor The...Read more
Korea Drug Development Fund invests in novel oncology candidate
Drug Discovery | News | 0 Comment | 15 Nov, 2022
South Korea-based SK Biopharmaceuticals has announced that the state-run Korea Drug Development Fund (KDDF) has decided ...Read more
Ono Pharmaceutical inks immuno-oncology partnership with Memo Therapeutics
Drug Discovery | News | 0 Comment | 04 Nov, 2022
Japan's Ono Pharmaceutical has entered a drug discovery agreement to discover and develop antibody drugs in the immuno...Read more
Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan
Drug Discovery | News | 0 Comment | 26 Sep, 2022
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...Read more
Huawei Cloud's Pangu drug molecule model accelerates new drug discovery
Drug Discovery | News | 0 Comment | 19 Sep, 2022
On September 19, HUAWEI CONNECT 2022 kicked off in Bangkok, Thailand. At the event, Ken Hu, Rotating and Actin...Read more
Innovent Biologics, Sanofi to develop cancer medicines for China
Drug Discovery | News | 0 Comment | 05 Aug, 2022
Innovent Biologics and Sanofi have announced a collaboration to bring innovative medicines to patients in China with dif...Read more
Sosei Heptares and AbbVie enter new multi-target collaboration worth $1.2 B
Drug Discovery | News | 0 Comment | 03 Aug, 2022
Japanese firm Sosei Group Corporation and US-based AbbVie, a research-based global biopharmaceutical company, have enter...Read more
Singapore develops new compounds to kill multi drug-resistant TB
Drug Discovery | News | 0 Comment | 04 Aug, 2022
With multi drug-resistant tuberculosis (TB) causing outbreaks in both developing and developed nations, new treatments a...Read more